F10 and Hepatic fibrosis: We have demonstrated that FXa and thrombin both independently and in synergy promote hepatic stellate cell activation and early inhibition of coagulation using an FXa inhibitor significantly reduced the rate of hepatic fibrosis and stellate cell activity in a mouse model of liver fibrosis compared to direct thrombin inhibition.